Ginkgo Bioworks DNA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$76.06M+5.8% | -$80.75M0.0% | -$80.76M-33.9% | -$60.3M+33.7% | -$90.96M+15.4% | ||
| $12.8M-6.3% | $13.66M-3.6% | $14.17M-13.3% | $16.34M+10.2% | $14.82M-5.3% | ||
| $15.85M-24.6% | $21.03M+17.9% | $17.84M-29.5% | $25.29M+45.5% | $17.39M-15.4% | ||
| -$46.69M+2.1% | -$47.68M-50.9% | -$31.61M+21.5% | -$40.25M+21.9% | -$51.52M-21.4% | ||
| $1.93M+38,560% | $5K— | $0-100% | $38K-99.5% | $7.62M-44.4% | ||
| $23.13M— | —— | -$72.82M-14.0% | -$63.89M+67.8% | -$198.68M-1,418% | ||
| -$19K-100% | $8.14M-18.1% | $9.94M+10,241% | -$98K+52.7% | -$207K-2.0% | ||
| -$23.7M— | —— | -$94.39M+9.3% | -$104.05M+58.4% | -$250.34M-349% | ||
| -$48.62M-2.0% | -$47.68M-50.9% | -$31.61M+21.6% | -$40.29M+31.9% | -$59.14M-5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ginkgo Bioworks generate?
- Ginkgo Bioworks (DNA) generated -$166.2M in operating cash flow over the trailing twelve months.
- What is Ginkgo Bioworks's free cash flow?
- After $2.0M of capital expenditures, Ginkgo Bioworks's free cash flow was -$168.2M over the trailing twelve months, up 51.3% year over year.
- Where does Ginkgo Bioworks's cash flow data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
